z-logo
open-access-imgOpen Access
Hyperprolactinemia in Cases of Infertility and Amenorrhea
Author(s) -
Furuhjelm Mirjam,
Rydner Thure,
Carlström Kjell
Publication year - 1980
Publication title -
acta obstetricia et gynecologica scandinavica
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.401
H-Index - 102
eISSN - 1600-0412
pISSN - 0001-6349
DOI - 10.3109/00016348009154630
Subject(s) - medicine , amenorrhea , infertility , gynecology , female infertility , primary amenorrhea , obstetrics , pregnancy , genetics , biology
Of 17 patients with longstanding (3–15 years, mean 7.7 years) amenorrhea and hyperprolactinemia, 8 developed their amenorrhea after the use of oral contraceptives (Group I) and 9 became amenorrhoic spontaneously (Group II). There were no differences between the groups with respect ot the basal serum levels of FSH, LH, low polar estrogens (estradiol‐17β + estrone) and prolactin. Tomography revealed pituitary adenoma in four patients. One of these developed symptoms of her tumor during pregnancy; the symptoms disappeared after delivery. The other patients with tumors are checked twice a year and have not yet received any treatment. The patients with no detectable tumors were treated with bromocriptine starting with 1.25 × 3 daily. The peripheral serum levels of prolactin, FSH, LH, low polar estrogens and progesterone were determined once a week and if the prolactin levels remained high, the bromocriptine dose was increased. All these patients started to menstruate as soon as prolactin returned to normal levels (below 25 μmg/l). All patients who wished to became pregnant, i. e. 6 patients. Three were delivered by cesarean section, one had a normal delivery and two are still pregnant. There was no difference between Group I and Group II in the dose required or in the duration of treatment before menstruation started. Three cases of galactorrhea were found.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here